The Effects of a Brief Emotion Regulation Program before Discharge on Medication Knowledge and Medication Adherence among Psychiatric Patients
Keywords:
caregiver participation, discharge medication counseling, medication adherence, medication knowledge, pharmacist, psychiatric patientsAbstract
This study aimed to examine the effectiveness of a brief emotion regulation program on medication knowledge and medication adherence among patients with psychiatric disease. The sample consisted of 40 participants, equally assigned to an experimental group and a control group, with 20 participants in each group. The experimental group received the brief emotion regulation program with caregiver participation,whereas the control group received routine nursing interventions. Outcomes were assessed at three time points: before the intervention, immediately after the intervention, and at follow-up. The research instruments included a demographic data record form, a medication knowledge assessment form, and a medication adherence assessment form for Thai patients. Data were analyzed using descriptive statistics and repeated measures analysis of variance. The results revealed that the experimental group’s medication knowledge scores increased from 5.15 ± 2.11 before the intervention to 9.75 ± 1.21 after the intervention and 10.25 ± 1.25 at follow-up. Medication adherence scores also increased from 30.75 ± 8.81 before the intervention to 44.70 ± 3.67 after the intervention and 46.45 ± 3.05 at follow-up. Significant interaction effects between time and group were found for both medication knowledge (F = 33.49, p < .001, partial η²
= .47) and medication adherence (F = 63.27, p < .001, partial η² = .63). In conclusion, the brief emotion regulation program with caregiver participation enhanced medication knowledge and medication adherence among psychiatric patients, and these effects were maintained during the follow-up period.
References
Higashi, K., Medic, G., Littlewood, K. J., Diez, T., Granström, O., & De Hert, M. (2013). Medication adherence in schizophrenia: Factors influencing adherence and consequences of nonadherence, a systematic literature review. Therapeutic Advances in Psychopharmacology, 3(4), 200–218. https://doi.org/10.1177/2045125312474019
Bonetti, A. F., Reis, W. C., Lombardi, N. F., Mendes, A. M., Netto, H. P., Rotta, I., Fernandez-Llimos, F., & Pontarolo, R. (2018). Pharmacist-led discharge medication counselling: A scoping review. Journal of Evaluation in Clinical Practice, 24(3), 570–579. https://doi.org/10.1111/jep.12933
Kelly, W. N., Ho, M.-J., Smith, T., Bullers, K., & Kumar, A. (2023). Association of pharmacist intervention counseling with medication adherence and quality of life: A systematic review and meta-analysis of randomized trials. Journal of the American Pharmacists Association, 63(4), 1095–1105. https://doi.org/10.1016/j.japh.2023.04.024
Syrnyk, M., & Glass, B. (2023). Pharmacist interventions in medication adherence in patients with mental health disorders: A scoping review. International Journal of Pharmacy Practice, 31(5), 449–458. https://doi.org/10.1093/ijpp/riad037
Cahaya, N., Kristina, S. A., Widayanti, A. W., & Green, J. (2022). Interventions to improve medication adherence in people with schizophrenia: A systematic review. Patient Preference and Adherence, 16, 2431–2449. https://doi.org/10.2147/PPA.S378951
Schulz, K. F., Altman, D. G., & Moher, D. (2010). CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. BMJ, 340, c332. https://doi.org/10.1136/bmj.c332
รสิกา อัครกรกุล และสงวน ลือเกียรติบัณฑิต. (2560). [ชื่อบทความ/รายละเอียดบรรณานุกรมของแบบประเมิน Medication Adherence Scale for Thais (MAST) ตามเอกสารต้นฉบับ].
Calvert, M., Blazeby, J., Altman, D. G., Revicki, D. A., Moher, D., & Brundage, M. D. (2013). Reporting of patient-reported outcomes in randomized trials: The CONSORT PRO extension. JAMA, 309(8), 814–822. https://doi.org/10.1001/jama.2013.879
IBM. (n.d.). GLM repeated measures. IBM Documentation.
